Sahajanand Medical Technologies IPO Details: Price, Dates & Financials
The Sahajanand Medical Technologies IPO is an ongoing mainboard Bookbuilding offer (OFS only) that opened on 15 October 2026. The Sahajanand Medical Technologies IPO will close on 19 October 2026, with an issue price of ₹344 per share. The Sahajanand Medical Technologies IPO has a face value of ₹1 and a lot size of 43 shares. The Sahajanand Medical Technologies IPO size aggregates up to ₹475 crore, listing on NSE & BSE on 23 October 2026. The Sahajanand Medical Technologies IPO allotment is expected on 21 October 2026.
On the financial front, the Sahajanand Medical Technologies IPO reported revenue of ₹354 crore for 30 Jun 2026, compared with ₹1,219 crore for 31 Mar 2026. The Sahajanand Medical Technologies IPO PAT was ₹15 crore against ₹69 crore. The Sahajanand Medical Technologies IPO EBITDA stood at ₹49 crore with a 13.81% margin. The Sahajanand Medical Technologies IPO net worth as of 30 Jun 2026 was ₹632 crore.
Always verify The Sahajanand Medical Technologies IPO details and GMP data with the official offer document before investing in the Sahajanand Medical Technologies IPO.
Financial Summary
Amount in ₹ Crore
Metric
30 Jun 2026
31 Mar 2026
31 Mar 2025
Total Assets
1,309
1,276
1,095
Revenue
354
1,219
1,036
PAT
15
69
25
EBITDA
49
171
128
Net Worth
632
616
545
Reserves
707
692
581
Total Borrowing
321
270
225
Sahajanand Medical Technologies IPO Financials FAQs
Revenue of Sahajanand Medical Technologies (Amount in ₹ Crore) — 30 Jun 2026: 354; 31 Mar 2026: 1,219; 31 Mar 2025: 1,036. Profit after tax (PAT) — 30 Jun 2026: 15; 31 Mar 2026: 69; 31 Mar 2025: 25.
EBITDA of Sahajanand Medical Technologies (Amount in ₹ Crore) — 30 Jun 2026: 49; 31 Mar 2026: 171; 31 Mar 2025: 128. The EBITDA margin is 13.81%.
Total assets — 30 Jun 2026: 1,309; 31 Mar 2026: 1,276; 31 Mar 2025: 1,095. Net worth — 30 Jun 2026: 632; 31 Mar 2026: 616; 31 Mar 2025: 545. Reserves & surplus — 30 Jun 2026: 707; 31 Mar 2026: 692; 31 Mar 2025: 581. (Amount in ₹ Crore)
Total borrowing of Sahajanand Medical Technologies (Amount in ₹ Crore) — 30 Jun 2026: 321; 31 Mar 2026: 270; 31 Mar 2025: 225. Debt-to-equity ratio: 0.33.
The financials shown for Sahajanand Medical Technologies IPO are taken from the company's offer document (DRHP/RHP/prospectus) filed with the exchange and SEBI, and are updated here when restated figures are published. Always cross-check with the official offer document before investing.
Look at the trend of revenue and PAT across periods, whether EBITDA is growing along with revenue, and whether net worth is rising while borrowings stay under control. The first column may be a part-year (interim) period, so compare full financial years with each other.
GMP and IPO data are unofficial and for information only — not investment advice.
Read the full disclaimer.
